C-RAD publishes Q1 2026 Interim Report
CEO Tomas Blomquist states it marks an important phase with increased pace and prioritization on value drivers.
See the latest news and media coverage for C-RAD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Surface Guided Radiation Therapy provider
c-rad.comLast updated
In short: C-RAD appointed Tomas Blomquist as CEO, launched a transformation program, and reported a 19% increase in Q1 2026 order intake to 115 MSEK.
CEO Tomas Blomquist states it marks an important phase with increased pace and prioritization on value drivers.
The meeting approves the accounts, resolves on dividend of 0.10 kr/share, grants discharge of liability, elects board with Thomas Axelsson as chairman and adopts LTIP 2026.
Order intake rose 19% to MSEK 115 while revenue fell 12% to MSEK 105; EBIT improved and a SEK 10m restructuring was recognized.
The annual report is available on the website in Swedish and English in ESEF format with XBRL tags. Printed version available at the office.
" Performance. Accountability. Execution. The beginning of a new chapter for C-RAD" First quarter January-MarchOrder intake increased 19 percent to MSEK 115 (97) (30 percent...
Latest news in brief - around the clock. Do you have a news tip? Contact Expressen at tipsa@expressen.se or send SMS/MMS to 0790-643 643...
The nomination committee for C-Rad proposes fertility company Vitrolife's former CEO Thomas Axelsson as new board chairman for the medical technology company...
By subscribing to the free subscription Affärsvärlden Free, you get a selection of all our material, as well as a daily newsletter with the latest news.
Track C-RAD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to C-RAD and other trending companies.